Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Robert L. Hudkins, Donna Bozyczko‐Coyne et al.|Bioorganic & Medicinal Chemistry Letters|2002Cited by 94
Discovery and Characterization of 6-{4-[3-(<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H<sub>3</sub>Receptor Inverse AgonistRobert L. Hudkins, Michael Williams, Rita Raddatz et al.|Journal of Medicinal Chemistry|2011Cited by 68
CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting ActivitiesRita Raddatz, Michael Williams, Robert L. Hudkins et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 58
Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cellsJoanne R. Mathiasen, Donna Bozyczko‐Coyne, Beth Ann McKenna et al.|Brain Research|2004Cited by 51
Mixed-Lineage Kinase 1 and Mixed-Lineage Kinase 3 Subtype-Selective Dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: Optimization, Mixed-Lineage Kinase 1 Crystallography, and Oral in Vivo Activity in 1-Methyl-4-phenyltetrahydropyridine ModelsRobert L. Hudkins, John P. Mallamo, James L. Diebold et al.|Journal of Medicinal Chemistry|2008Cited by 43